Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of 13-cis Retinoic Acid (Isotretinoin) for the Treatment of Men With Oligoasthenoteratozoospermia

NCT02061384 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02061384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02061384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of 13-cis Retinoic Acid (Isotretinoin) for the Treatment of Men With Oligoasthenoteratozoospermia
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

klinefelter's syndrome, male infertility, y-chromosome microdeletions